Intratumor delivery of an mRNA-encoding cytokine mixture composed of IL12, IFN-α, GM-CSF, IL15, IL12, IL23, IL36, and OX40L promoted antitumor immunity and tumor regression in preclinical tumor models and clinical trials.50 The gene discussed is TNFSF4; the disease is neoplasm.